신장 기능과 틸로미어

키워드

참고문헌 (82)

1. Samak MJ, "Cystatin C and aging success", Arch Intern Med, 168, pp.147~153 (2008)
2. Khan EM, "Epidermal growth factor receptor exposed to cigarette smoke is aberrantly activated and undergoes perinuclear trafficking", FASEB J, 22, pp.910~917 (2008)
3. Cherkas LF, "The association between physical activity in leisure time and leukocyte telomere length", Arch Intern Med, 168, pp.154~158 (2008)
4. Demissie S, "Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart study", Aging Cell, 5, pp.325~330 (2006)
5. Aviv A, "Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation", J Clin Endocrinol Metab, 91, pp.635~640 (2006)
6. Edo MD, "Aging, telomeres, and atherosclerosis", Cardiovas Res, 66, pp.213~221 (2005)
7. von Zglinicki T, "Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence", Exp Cell Res, 220, pp.186~193 (1995)
8. Harley CB, "Telomeres shorten during ageing of human fibroblasts", Nature, 345, pp.458~460 (1990)
9. Dimri GP, "A biomarker that identifies senescent human cells in culture and in aging skin in vivo", Proc Natl Acad Sci USA, 92, pp.9363~9367 (1995)
10. Wilmut AE, "Viable offspring derived from fetal and adult mammalian cells", Nature, 385, pp.810~813 (1997)
11. Bailey SM, "Telomeres, chromosome instability and cancer", Nucleic Acids Res, 34, pp.2408~2417 (2006)
12. Nordfjall K, "Telomere length and heredity: indications of paternal ingeritance", Proc Natl Acad Sci USA, 102, pp.16374~16378 (2005)
13. Shao L, "Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer", J Urol, 178, pp.1492~1496 (2007)
14. Sugimura K, "Telomerase activity in human renal cell carcinoma", BJU Int, 83, pp.693~697 (1999)
15. Famulski KS, "Molecular events in kidney ageing", Curr Opin Nephrol Hypertension, 14, pp.243~248 (2005)
16. Wu X, "Telomere dysfunction: a potential cancer predisposition factor", J Natl Cancer Inst, 95, pp.1211~1218 (2003)
17. Passos JF, "DNA damage in telomeres and mitochondria during cellular senescence:is there a connection?", Nucleic Acids Res, 335, pp.7505~7513 (2007)
18. Kraytsberg Y, "Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons", Nat Genet, 38, pp.518~520 (2006)
19. Trifunovic A., "Mitochondrial DNA and ageing", Biochim Biophys Acta, 1757, pp.611~617 (2006)
20. Kim SJ, "Neoroscience", pp.666~667 (2007), Sinauer Assoc. Inc. and WORLD SCIENCE Pub Co.
21. Corey DR, "Telomerase inhibition, oligonucleotides, and clinical trials", Oncogene, 21, pp.631~637 (2002)
22. 서동철, "Comparative binding of antitumor drugs to DNA containing the telomere repeat sequence", Experimental and Molecular Medicine, 34(5), pp.326~331 (2002), 생화학분자생물학회
23. Boukamp P., "Telomeres rather than telomerase a key target for anti-cancer therapy?", Exp Dermatol, 16, pp.71~79 (2006)
24. Neidle S., "Telomere maintenance as a target for anticancer drug discovery", Nat Rev Drug Discov, 1, pp.383~393 (2002)
25. Baird DM, "New developments in telomere length analysis", Exp Gerontol, 40, pp.363~368 (2005)
26. Der-Sarkissian H, "The shortest telomeres drive Karyotype evolution in transformed cells", Oncogene, 23, pp.1221~1228 (2004)
27. Wellinger RJ, "Evidence for a new step in telomere maintenance", Cell, 85, pp.423~433 (1996)
28. Zakian VA, "Telomeres: Beginning to understand the end", Science, 270, pp.1601~1607 (1995)
29. Shay JW, "When do telomeres matter?", Science, 291, pp.839~840 (2001)
30. Makarov VL, "Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening", Cell, 88, pp.657~666 (1997)
31. Hayflick L, "The serial cultivation of human diploid cell strains", Exp Cell Res, 25, pp.585~621 (1961)
32. Lansdorp PM, "Heterogeneity in telomere length of human chromosome", Hum Mol Genet, 5, pp.685~691 (1996)
33. Collado M, "Cellular senescence in cancer and aging", Cell, 130, pp.223~233 (2007)
34. von Zglinicki T., "Telomere-driven replicative senescence is a stress response", Nat Biotechnol, 21, pp.229~230 (2003)
35. Keys B., "Telomere shortening in human fibroblasts is not dependent on the size of the telomeric-3`-overhang", Aging Cell, 3, pp.103~109 (2004)
36. Sfelr A, "Telomere-end processing: the terminal nucleotides of human chromosomes", Mol Cell, 18, pp.131~138 (2005)
37. Reveal PM, "Synthesis of the mammalian telomere lagging strand in vitro", J Biol Chem, 272, pp.11678~11681 (1997)
38. Heydari AR, "Caloric restriction and genomic stability", Nucleic Acids Res, 35, pp.7485~7496 (2007)
39. Stuart JA, "Mitochondrial and nuclear DNA base excision repair are affected differently by caloric restriction", FASEB J, 18, pp.595~597 (2004)
40. Hamilton ML, "Does oxidative damage to DNA increase with age?", Proc Natl Acad Sci USA, 98, pp.10469~10474 (2001)
41. Chen JH, "DNA damage, cellular senescence and organismal ageing: caual or correlative?", Nucleic Acids Res, 35, pp.7417~7428 (2007)
42. Kim WY, "The regulation of INK4", ARF in cancer and aging, 2006, pp.127, 265~275
43. Herbig U, "Cellular senescence in aging primates", Science, 311, pp.1257~ (2006)
44. Bender A, "High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease", Nat. Genet, 38, pp.515~517 (2006)
45. Kraytsberg Y, "Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons", Nat Genet, 38, pp.518~520 (2006)
46. Krishman KJ, "The ageing mitochondrial genome", Nucleic Acids Res, 35, pp.7399~7405 (2007)
47. Carter RW, "Mitochondrial diversity within modern human populations", Nucleic Acids Res, 35, pp.3039~3045 (2007)
48. Schwartz M, "Paternal inheritance of mitochondrial DNA", N Engl J Med, 347, pp.576~580 (2002)
49. Stoneking M., "Human evolution and the mitochondrial genome", Curr Opin Genet Dev, 6, pp.731~736 (1996)
50. Templeton AR., "Out of Africa again and again", Nature, 416, pp.45~51 (2002)
51. Baird DM, "Wynford-Thomas D, Kipling D. Extensive allelic variation and ultrashort telomeres in senescent human cells", Nat Genet, 33, pp.203~207 (2003)
52. Neidle S., "The structure of telomeric DNA", Curr Opin Struct Biol, 13, pp.275~283 (2003)
53. Blasco M., "Telomeres and human disease ageing, cancer and beyond", Nat Rev Genet, 6, pp.611~622 (2005)
54. Zou Y, "Does a sentinel or a subset of short telomeres determine replicative senescence?", Mol Biol Cell, 15, pp.3709~3718 (2004)
55. Hermann MT, "The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability", Cell, 107, pp.67~77 (2001)
56. Lansdorp PM., "Telomeres, stem cells, and hematology", Blood, 111, pp.1759~1766 (2008)
57. Izumi H, "High telomerase activity correlates with the stabilities of genome and DNA ploidy in renal cell carcinoma", Neoplasia, 4, pp.103~111 (2002)
58. Lechler R., "Organ transplantation-how much of the promise has been realized?", Nat Med, 11, pp.605~613 (2005)
59. Wong KK, "Walking the telomere plank into cancer", J Natl Cancer Inst, 95, pp.1184~1186 (2003)
60. Hales CN, "Suicide of the nephron", Lancet, 357, pp.136~137 (2001)
61. Sfeir AJ, "Fine-tuning the chromosome ends: the last base of human telomeres", Cell Cycle, 4, pp.1467~1470 (2005)
62. Jennings BJ., "Early growth determines longevity in male rats and may be related to telomere shortening in the kidney", FEBS Lett, 448, pp.4~8 (1999)
63. Wu X., "Telomere dysfunction: a potential cancer predisposition factor", J Natl Cancer Inst, 95, pp.1211~1218 (2003)
64. Joosten SA, "Telomere shortening and cellular senescence in a model of chronic renal allograft rejection", Amer J Pathodol, 162, pp.1305~1312 (2003)
65. Cherif H, "Aging and telomeres: a study into organ-and gender-specific telomere shortening", Nucleic Acids Res, 31, pp.1576~1583 (2003)
66. Garcia CK, "Human disease of telomerase dysfunction: insights into tissue aging", Nucleic Acids Res, 35, pp.7406~7416 (2007)
67. Blackburn EH., "Telomerases", Annu Rev Biochem, 61, pp.113~129 (1992)
68. Greider C., "Identification of a specific terminal transferase activity in Tetrahymena extracts", Cell, 51, pp.887~898 (1985)
69. Epel ES., "Adler NE. Morrow JD. Accelerated telomere shortening in response to life stress", Proc Natl Acd Sci USA, 1010, pp.17312~17315 (2004)
70. Valdes AM, "Obesity, cigarette smoking, and telomere length in women", Lancet, 366, pp.662~664 (2005)
71. Oikawa S., "Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening", FEBS Lett, 453, pp.365~368 (1999)
72. Henle ES, "Sequence-specific DNA cleavage by Fe2+-mediated fenton reactions has possible biological implications", J Biol Chem, 274, pp.962~971 (1999)
73. Beal MF., "Less stress, longer life", Nat. Med, 11, pp.598~599 (2005)
74. Rodier F, "Two faces of p53: aging and tumor suppression", Nucleic Acids Res, 35, pp.7475~7484 (2007)
75. Kastan MB., "Wid-type p53: Tumors can`t stand it", Cell, 128, pp.837~840 (2007)
76. Kirkwood TBL., "Understanding the odd science of aging", Cell, 120, pp.437~447 (2005)
77. Beneke S., "Poly(ADP-ribosyl)ation in mammalian ageing", Nucleic Acids Res, 35, pp.7456~7465 (2007)
78. Itahana K, "Mechanisms of cellular senescence in human and mouse cells", Biogerontol, 5, pp.1~10 (2004)
79. Cawthon RM., "Association between telomere length in blood and mortality in people aged 60 years or older", Lancet, 361, pp.393~395 (2003)
80. Rezler EM., "Telomere inhibition and telomere disruption as processes for drug targeting", Annu Rev Pharmacol Toxicol, 43, pp.359~379 (2003)
81. Bearss DJ, "Telomere maintenance mechanisms as a target for drug development", Oncogene, 19, pp.6632~6641 (2000)
82. Burhans WC., "DNA replication stress, genome instability and aging", Nucleic Acids Res, 35, pp.7545~7556 (2007)

관련 논문AI추천